BTIG Maintains Buy on Praxis Precision Medicine, Raises Price Target to $826

Benzinga Newsdesk www.benzinga.com Positive 86.8%

Neg 0% Neu 0% Pos 86.8%

BTIG analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $810 to $826.